Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
CRISPR Therapeutics AG Financials Banner

CRISPR Therapeutics AG Financials

CRSP Stock Analysis

Page title

Section title

CRSP Income Statement Key Metrics

  • Revenue(TTM)201.62 M
  • Gross Profit(TTM)61.70 M
  • EBITDA(TTM)-317.82 M
  • Net Income(TTM)-239.59 M
  • EPS Diluted(TTM)-2.8299999999999996

Decode CRSP's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

CRSP earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of CRSP (0.648) is lower than the average of its peers (0.819).

Net Profit Margin vs Peers

Net profit margin ratio of CRSP (-0.415) is higher than the average of its peers (-3.764).

CRSP Return on Equity

See how efficiently CRSP generates profit for it's shareholders.

-8.16%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of CRSP (-0.082) is higher than the average of its peers (-0.175).

Return on Equity Growth

CRSP's Return on Equity has grown significantly over the past 10 years, increasing by over 21.81%.

CRSP Revenue Growth

See how CRSP has grown it's revenue over the past 10 years.


Revenue Growth

CRSP's revenue has grown significantly over the past 10 years, increasing by over 0%.

CRSP FY, 2023 Revenue Breakdown

See how CRSP converts it's revenue into profit.

CRSP Balance Sheet Health

CRSP Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

CRSP financial position analysis

Short Term Liabilities

CRSP's short term assets($2B) can safely cover it's short term liabilities($109M).

Long Term Liabilities

CRSP's short term assets($2B) can safely cover it's long term liabilities($238M).

CRSP Debt to Equity